首页 | 本学科首页   官方微博 | 高级检索  
     

应用Alarma blue测定法评价软肝煎药物血清对HSC/T6增殖的影响
引用本文:曹俊,王宗铁,田大伟,李权,缪胜菊. 应用Alarma blue测定法评价软肝煎药物血清对HSC/T6增殖的影响[J]. 中国中西医结合消化杂志, 2002, 10(4): 219-222
作者姓名:曹俊  王宗铁  田大伟  李权  缪胜菊
作者单位:1. 湖北中医学院99级研究生,武汉,430061
2. 湖北省新华医院,武汉,430015
摘    要:目的:应用Alarma blue测定法评价中药复方软肝煎对HSC/T6增殖的影响,方法:实验分为小牛血清,大鼠血清及药物血清3组,各组再分为5%,10%及20%3个浓度组,每组4只大鼠,利用中药血清药理学,通过MTT法和Alarma blue测定法测定软肝煎药物血清影响HSC/T6增殖的情况。结果:在MTT测定法中,与小牛血清组相比,大鼠血清组的5%浓度差异有显著性意义(P<0.05),10%,20%浓度差异有非常显著性意义(P<0.01),药物血清组各浓度差异均有非常显著性意义(P<0.01),与大鼠血清组相比,药物血清组的5%,10%浓度差异有显著性意义(P<0.05),20%浓度差异有非常显著性意义(P<0.01),在Alarma blue测定法中,24h时,与小牛血清组比较,大鼠血清组与药物血清组的10%浓度差异均有非常显著性意义(P<0.01),与大鼠血清组相比,药物血清组的10%浓度差异有显著性意义(P<0.05,)30h时,与小牛血清组比较,大鼠血清组的10%浓度及药物血清组的10%学差异均有显著性意义(P<0.05,P<0.01),与大鼠血清组相比,药物血清组的10%浓度差异有非常显著性意义(P<0.01),结论:软肝煎能抑制HSC/T6的增殖,具有抗肝纤维化作用;Alarma blue测定法是一种可靠的方法,不同动物种属的血清对肝星状细胞增殖影响不同,在培养系中使用单一的血清为好。

关 键 词:肝纤维化 Alarmablue 肝星状细胞 软肝煎方 血清药理学

Effect of Serum Containing Ruanganjian Decoction on Proliferation of HSC/T6 by Alarma Blue Assay
CAO Jun,WANG Zongtie,TIAN Dawei,et al Hubei College of TCM,Wuhan. Effect of Serum Containing Ruanganjian Decoction on Proliferation of HSC/T6 by Alarma Blue Assay[J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2002, 10(4): 219-222
Authors:CAO Jun  WANG Zongtie  TIAN Dawei  et al Hubei College of TCM  Wuhan
Affiliation:CAO Jun,WANG Zongtie,TIAN Dawei,et al Hubei College of TCM,Wuhan 430061
Abstract:Objective:To evaluate the effect of serum containing Ruanganjian decoction on the proliferation of HSC/T6 by alarma blue assay.Methods:All of the sera were divided into 3 groups: calf serum group, rat serum group and drug-containing serum group. Each group was subdivided into three subgroups of 5 %, 10 % and 20 % (n=4 each). MTT assay and alarma blue assay were used to measure the effect of Ruanganjian decoction on the proliferation of HSC/T6.Results: In the groups assayed with MTT, rat serum of 5 % could inhibit HSC/T6 proliferation with more remarkable effect than calf serum (P< 0.05), while rat sera of 10 % and 20 % with very significant difference (P < 0.01); There was significant difference among different subgroups of drug-containing serum (P< 0.01); As compared with rat serum, drug-containing sera of 5 % and 10 % could inhibit HSC/T6 proliferation with remarkable difference (P< 0.05), while serum of 20 % with very significant difference (P< 0.01). In the groups assayed with alamar blue, as compared with calf serum, rat and drug-containing sera of 10 % could inhibit HSC/T6 proliferation after 24 h with more significant difference (P< 0.01); As compared with rat serum, drug-containing serum of 10 % could inhibit HSC/T6 proliferation with statistical difference (P< 0.05); As compared with calf serum, rat serum of 10 % could inhibit HSC/T6 proliferation after 30 h with significant difference (P< 0.05), while drug-containing serum of 10 % with more significant difference (P< 0.01); As compared with rat serum, drug-containig serum of 10 % could inhibit HSC/T6 proliferation after 30 h with very significant difference (P< 0.01). Conclusion: (1) Serum containing Ruanganjian decoction could inhibit the proliferation of HSC/T6, antagonize hepatic fibrosis. (2) Alarma blue assay was a creditable method. (3) Different animal sera had different effects on HSC proliferation and it was preferable to use a single animal serum in cultured medium.
Keywords:hepatic fibrosis  alarma blue  HSC  Ruanganjian decoction  serum pharmacology
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号